NCT03741231View on ClinicalTrials.gov

18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
MelanomaNSCLCPositron-Emission TomographyImmunotherapy18F-FDG
Trial Locations (3)

29609

CHRU de Brest, Brest

Unknown

CH de LANDERNEAU, Landerneau

Centre Hospitalier de Morlaix, Morlaix

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT03741231 - 18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy | Biotech Hunter | Biotech Hunter